Sernova (TSE:SVA) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sernova Corp, a biotech firm advancing cell therapies for chronic diseases, appoints Jonathan Rigby as Executive Chairman to bolster capital market efforts and company growth. The leadership shuffle, marked by the resignation of former Chairman Brett Whalen, signals a strategic move to enhance Sernova’s market presence. Rigby, with a successful track record in biotech ventures, pledges to leverage his experience to propel the company and aid individuals like himself affected by Type 1 Diabetes.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
